SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.81-4.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (8293)1/14/1999 10:16:00 PM
From: aknahow  Read Replies (1) of 17367
 
Mr. Prill, my offer still holds. Site is as good as always. Limited in some respects, however.<g>

Remember you can just make something up but if I believe it is the truth I will provide you with the true URL for XOMA's most current web site.

BTW if the DSMB has not met or does not meet this week or next I don't think it matters that much. The accrual rate is ramping up and it would be logical that they will get to the numbers they need, in a short time, regardless of how one thinks about what is needed to end the trials. I regret that I could not get better info. from any web site on the mortality rate in the U.K., but I am now convinced that a lower mortality rate which could be caused by Neuprex being effective and or faster and better treatment, has caused the trials to continue as XOMA might want or need a few more accruals to improve the confidence level and or comply with whatever the FDA wanted from the start.

O.K. Opala, time to tell, what is behind the name?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext